Papers

1

Total Citations

3

H-Index

1

About

Dr. Xuemei Tian is a pioneering urologic surgeon whose research focuses on advancing minimally invasive surgical techniques for prostate cancer treatment, particularly through robotic-assisted laparoscopic radical prostatectomy. Her most notable contribution is a landmark prospective, controlled, nonrandomized trial comparing single-incision versus standard multi-incision robot-assisted laparoscopic radical prostatectomy, which has garnered significant attention in the field. This work, published in 2024, evaluated perioperative and functional outcomes between improved port-free single-site robot-assisted laparoscopic radical prostatectomy (pf-ssRARP) and standard multi-port robot-assisted radical prostatectomy (MPRARP) in 372 consecutive patients. Dr. Tian’s research demonstrates her commitment to refining surgical approaches that reduce patient trauma while maintaining oncologic efficacy. Her comparative analysis provides crucial evidence for the potential benefits of single-incision techniques, including improved cosmetic outcomes and potentially faster recovery. As a researcher at the forefront of urologic oncology, Dr. Tian’s work continues to shape clinical practice by offering surgeons and patients evidence-based options for prostate cancer management, with her most cited paper already influencing discussions on surgical innovation in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of perioperative and functional outcomes of single-incision versus standard multi-incision robot-assisted laparoscopic radical prostatectomy: a prospective, controlled, nonrandomized trial
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of Electronic Science and Technology of China

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago